Trials / Withdrawn
WithdrawnNCT05671913
Scheduled Intranasal Ketamine
Effects of Opioid Requirements With Scheduled Intranasal Ketamine During Admission for Traumatic Pain
- Status
- Withdrawn
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Sanford Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to determine if scheduled intranasal ketamine effects opioid requirements in adult trauma patients with moderate to severe pain in the inpatient setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketamine | Treatment arm |
| DRUG | Placebo | Control arm |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2025-12-31
- Completion
- 2026-01-01
- First posted
- 2023-01-05
- Last updated
- 2023-04-05
Source: ClinicalTrials.gov record NCT05671913. Inclusion in this directory is not an endorsement.